Close Menu

NEW YORK ─ RenalytixAI on Thursday said it has proposed a dual listing on the Nasdaq in a registration statement with the US Securities and Exchange Commission.

New York-based RenalytixAI is also planning a public offering of its American Depositary Shares (ADS), each of which will represent one or a number of its ordinary shares in the US, and it is proposing a concurrent private placement of its ordinary shares in Europe and other countries outside of the US as part of a global offering.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.